20th KM, Hosur Road
India - Map
Phone: 91 80 2808 2808
Fax: 91 80 2852 3423
Biocon Limited, an integrated healthcare company, develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, and narrow spectrum antibiotics; and biosimilars comprising human insulin, insulin glargine, insulin lispro, insulin aspart, erythropoietin, filgrastim, streptokinase, and monoclonal antibodies. The company also provides branded formulations in the areas of cardiology, diabetology, oncology, nephrology, cardiology, immunotherapy, and comprehensive care; and out-licensing services. In addition, it offers contract manufacturing services, including mammalian cell culture fermentation, microbial cell culture fermentation, and synthetic chemistry to small-to-medium sized pharmaceutical and biotech companies; undertakes clinical research activities on discovering new biomarkers; and provides integrated contract research services to support discovery and development, for small and large molecules. The companys principal brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab), and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It serves its customers in approximately 85 countries. The company was founded in 1978 and is headquartered in Bengaluru, India.
|Ms. Kiran Mazumdar-Shaw B.Sc (Hons), PGD in Malting & Brewing,
Founder, Chairperson, Managing Director, Member of Share Transfer Committee, Member of Stakeholders Relationship Committee and Member of Corp. Social Responsibility Committee
|Dr. Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.),
Chief Exec. Officer, Joint Managing Director and Exec. Director
|Mr. John Mccallum Marshall Shaw M.A (Hons),
Vice Chairman, Member of Share Transfer Committee and Member of Stakeholders Relationship Committee
|Mr. Siddharth Mittal BCom, CA, CPA,
Chief Financial Officer and Pres of Fin.
|Mr. G. Kiran Kumar ,
Assistant VP of Fin., Compliance Officer and Company Sec.
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in INR.|